ReHydration

Wirkstoff: ADENOSINE CYCLIC PHOSPHATE, ARABICA COFFEE BEAN, SUS SCROFA ADRENAL GLAND, BOS TAURUS HYPOTHALAMUS, DIBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE, SILICON DIOXIDE, SMILAX ORNATA ROOT, TARAXACUM OFFICINALE, THYROID, UNSPECIFIED

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · ADENOSINE CYCLIC PHOSPHATE 12 [hp_X]/59.1mL, ARABICA COFFEE BEAN 9 [hp_X]/59.1mL, SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL, BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL, DIBASIC POTASSIUM PHOSPHATE 6 [hp_X]/59.1mL, SODIUM CHLORIDE 8 [hp_X]/59.1mL, SILICON DIOXIDE 12 [hp_X]/59.1mL, SMILAX ORNATA ROOT 4 [hp_X]/59.1mL, TARAXACUM OFFICINALE 4 [hp_X]/59.1mL, THYROID, UNSPECIFIED 12 [hp_X]/59.1mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energetix Corporation

Geprüft 2026-10-09 · openFDA NDC